{"pmid":32425014,"title":"The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact.","text":["The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact.","SARS-CoV-2 infection, responsible for COVID-19, can determine cardiac events, which require a quick diagnosis and management, and should not be overlooked due to the presence of COVID-19 infection. In some cases, cardiovascular symptoms can also be the first and only manifestation of SARS-CoV-2 infection. In patients with COVID-19, the full cardiovascular disease diagnostic algorithm can be hindered by logistic restrain mainly derived from the difficulty of transporting patients in critical conditions to Radiology or Hemodynamics wards. The echocardiography in SARS-CoV-2 pandemic can help for differential diagnosis of cardiac events, which can be related or unrelated by the infection and can likely impact on short-term prognosis. Indeed, transthoracic echocardiography plays a key role in the screen for CV complications of COVID-19 infection: it must be focused cardiac ultrasound study (FoCUS) performed at bedside. All transthoracic, transesophageal and stress echocardiograms in patients in which test results are unlikely to change the management strategy should be postponed.","Monaldi Arch Chest Dis","Pacileo, Mario","Giallauria, Francesco","Savarese, Cristina","Cirillo, Teresa","Crescibene, Fabio","Di Lorenzo, Anna","Ferrillo, Mariacarla","Calabrese, Maria Grazia","Vigorito, Carlo","D'Andrea, Antonello","32425014"],"abstract":["SARS-CoV-2 infection, responsible for COVID-19, can determine cardiac events, which require a quick diagnosis and management, and should not be overlooked due to the presence of COVID-19 infection. In some cases, cardiovascular symptoms can also be the first and only manifestation of SARS-CoV-2 infection. In patients with COVID-19, the full cardiovascular disease diagnostic algorithm can be hindered by logistic restrain mainly derived from the difficulty of transporting patients in critical conditions to Radiology or Hemodynamics wards. The echocardiography in SARS-CoV-2 pandemic can help for differential diagnosis of cardiac events, which can be related or unrelated by the infection and can likely impact on short-term prognosis. Indeed, transthoracic echocardiography plays a key role in the screen for CV complications of COVID-19 infection: it must be focused cardiac ultrasound study (FoCUS) performed at bedside. All transthoracic, transesophageal and stress echocardiograms in patients in which test results are unlikely to change the management strategy should be postponed."],"journal":"Monaldi Arch Chest Dis","authors":["Pacileo, Mario","Giallauria, Francesco","Savarese, Cristina","Cirillo, Teresa","Crescibene, Fabio","Di Lorenzo, Anna","Ferrillo, Mariacarla","Calabrese, Maria Grazia","Vigorito, Carlo","D'Andrea, Antonello"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425014","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.4081/monaldi.2020.1358","topics":["Prevention","Diagnosis"],"weight":1,"_version_":1667352728706220033,"score":9.490897,"similar":[{"pmid":32503706,"title":"Bedside Focused Cardiac Ultrasound in COVID-19 from the Wuhan Epicenter: The Role of Cardiac Point-of-Care Ultrasound, Limited Transthoracic Echocardiography, and Critical Care Echocardiography.","text":["Bedside Focused Cardiac Ultrasound in COVID-19 from the Wuhan Epicenter: The Role of Cardiac Point-of-Care Ultrasound, Limited Transthoracic Echocardiography, and Critical Care Echocardiography.","BACKGROUND: Three cases of the application of focused cardiac ultrasound in patients with coronavirus disease 2019 are presented. METHODS: Cardiac point-of-care ultrasound, limited transthoracic echocardiography, and critical care echocardiography were applied in cases of heart failure, pulmonary embolism, and myocarditis with thrombus respectively. RESULTS: The impact on patient management and the global context of each presentation are discussed. CONCLUSIONS: Focused cardiac point-of-care ultrasound played an important, front-line role in the bedside management of patients during the COVID-19 pandemic in Wuhan, China.","J Am Soc Echocardiogr","Zhang, Li","Wang, Bin","Zhou, Jianhua","Kirkpatrick, James","Xie, Mingxing","Johri, Amer M","32503706"],"abstract":["BACKGROUND: Three cases of the application of focused cardiac ultrasound in patients with coronavirus disease 2019 are presented. METHODS: Cardiac point-of-care ultrasound, limited transthoracic echocardiography, and critical care echocardiography were applied in cases of heart failure, pulmonary embolism, and myocarditis with thrombus respectively. RESULTS: The impact on patient management and the global context of each presentation are discussed. CONCLUSIONS: Focused cardiac point-of-care ultrasound played an important, front-line role in the bedside management of patients during the COVID-19 pandemic in Wuhan, China."],"journal":"J Am Soc Echocardiogr","authors":["Zhang, Li","Wang, Bin","Zhou, Jianhua","Kirkpatrick, James","Xie, Mingxing","Johri, Amer M"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503706","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.echo.2020.04.004","keywords":["covid-19 infection","critical care echocardiography","focused cardiac ultrasound","limited transthoracic echocardiography","point-of-care ultrasound"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1668892488266416128,"score":358.13312},{"pmid":32241097,"title":"Echocardiography during the coronavirus disease 2019 (COVID-19) pandemic: expert opinion of the Working Group on Echocardiography of the Polish Cardiac Society.","text":["Echocardiography during the coronavirus disease 2019 (COVID-19) pandemic: expert opinion of the Working Group on Echocardiography of the Polish Cardiac Society.","Transthoracic and transesophageal echocardiography may be required in patients with coronavirus disease 2019 (COVID19), resulting in direct contact with the patient and risk of transmitting the infection from patients to medical personnel. Therefore, we recommend to perform problemoriented timelimited transthoracic examinations. Whenever possible, examinations should be analyzed offline, outside the isolation zones. Transesophageal echocardiography is considered an aerosolgenerating procedure and should be performed only as a lifesaving procedure. Personnel should use appropriate personal protection equipment in the immediate vicinity of the patients in accordance with the relevant guidelines.","Kardiol Pol","Gackowski, Andrzej","Lipczynska, Magdalena","Lipiec, Piotr","Szymanski, Piotr","32241097"],"abstract":["Transthoracic and transesophageal echocardiography may be required in patients with coronavirus disease 2019 (COVID19), resulting in direct contact with the patient and risk of transmitting the infection from patients to medical personnel. Therefore, we recommend to perform problemoriented timelimited transthoracic examinations. Whenever possible, examinations should be analyzed offline, outside the isolation zones. Transesophageal echocardiography is considered an aerosolgenerating procedure and should be performed only as a lifesaving procedure. Personnel should use appropriate personal protection equipment in the immediate vicinity of the patients in accordance with the relevant guidelines."],"journal":"Kardiol Pol","authors":["Gackowski, Andrzej","Lipczynska, Magdalena","Lipiec, Piotr","Szymanski, Piotr"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241097","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.33963/KP.15265","locations":["Transthoracic"],"topics":["Prevention"],"weight":1,"_version_":1666138492161228800,"score":317.2999},{"pmid":32418875,"title":"COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ).","text":["COVID-19 and Acute Heart Failure: Screening the Critically Ill - A Position Statement of the Cardiac Society of Australia and New Zealand (CSANZ).","Up to one-third of COVID-19 patients admitted to intensive care develop an acute cardiomyopathy, which may represent myocarditis or stress cardiomyopathy. Further, while mortality in older patients with COVID-19 appears related to multi-organ failure complicating acute respiratory distress syndrome (ARDS), the cause of death in younger patients may be related to acute heart failure. Cardiac involvement needs to be considered early on in critically ill COVID-19 patients, and even after the acute respiratory phase is passing. This Statement presents a screening algorithm to better identify COVID-19 patients at risk for severe heart failure and circulatory collapse, while balancing the need to protect health care workers and preserve personal protective equipment (PPE). The significance of serum troponin levels and the role of telemetry and targeted transthoracic echocardiography (TTE) in patient investigation and management are addressed, as are fundamental considerations in the management of acute heart failure in COVID-19 patients.","Heart Lung Circ","Lal, Sean","Hayward, Christopher S","De Pasquale, Carmine","Kaye, David","Javorsky, George","Bergin, Peter","Atherton, John J","Ilton, Marcus K","Weintraub, Robert G","Nair, Priya","Rudas, Mate","Dembo, Lawrence","Doughty, Robert N","Kumarasinghe, Gayathri","Juergens, Craig","Bannon, Paul G","Bart, Nicole K","Chow, Clara K","Lattimore, Jo-Dee","Kritharides, Leonard","Totaro, Richard","Macdonald, Peter S","32418875"],"abstract":["Up to one-third of COVID-19 patients admitted to intensive care develop an acute cardiomyopathy, which may represent myocarditis or stress cardiomyopathy. Further, while mortality in older patients with COVID-19 appears related to multi-organ failure complicating acute respiratory distress syndrome (ARDS), the cause of death in younger patients may be related to acute heart failure. Cardiac involvement needs to be considered early on in critically ill COVID-19 patients, and even after the acute respiratory phase is passing. This Statement presents a screening algorithm to better identify COVID-19 patients at risk for severe heart failure and circulatory collapse, while balancing the need to protect health care workers and preserve personal protective equipment (PPE). The significance of serum troponin levels and the role of telemetry and targeted transthoracic echocardiography (TTE) in patient investigation and management are addressed, as are fundamental considerations in the management of acute heart failure in COVID-19 patients."],"journal":"Heart Lung Circ","authors":["Lal, Sean","Hayward, Christopher S","De Pasquale, Carmine","Kaye, David","Javorsky, George","Bergin, Peter","Atherton, John J","Ilton, Marcus K","Weintraub, Robert G","Nair, Priya","Rudas, Mate","Dembo, Lawrence","Doughty, Robert N","Kumarasinghe, Gayathri","Juergens, Craig","Bannon, Paul G","Bart, Nicole K","Chow, Clara K","Lattimore, Jo-Dee","Kritharides, Leonard","Totaro, Richard","Macdonald, Peter S"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32418875","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.hlc.2020.04.005","keywords":["acute cardiomyopathy","covid-19","high sensitivity troponin","myocarditis","screening algorithm","targeted transthoracic echocardiogram"],"locations":["New Zealand"],"countries":["New Zealand"],"countries_codes":["NZL|New Zealand"],"topics":["Prevention"],"weight":1,"_version_":1667159284390035457,"score":225.79874},{"pmid":32415767,"title":"Valvular and structural heart disease management during the COVID-19 pandemic. Expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.","text":["Valvular and structural heart disease management during the COVID-19 pandemic. Expert opinion of the Working Group on Valvular Heart Diseases, the Working Group on Cardiac Surgery, and the Association of Cardiovascular Interventions of the Polish Cardiac Society.","Ongoing pandemics of SARS-CoV-2 coronavirus disease 2019 (COVID-19) represents a major challenge for healthcare. Beside the proven involvement of cardiovascular system in COVID-19, increased healthcare system resources are redirected towards handling infected patients and thus induce major changes in access to services and priorities in the management of patients with unrelated chronic cardiovascular disease. This document, created by task force involving Working Groups on Valvular Heart Disease and Cardiac Surgery as well as Association of Cardiovascular Intervention, Polish Cardiac Society proposes modifications of diagnostic pathways, principles of healthcare professionals protection and guidelines for treatment according to triage and prioritization. Valvular heart teams should continue working with utilization of telemedicine and digital technology. Diagnostic tests must be simplified or deferred to minimize potentially dangerous aerosol generating procedures such as transesophageal echocardiography or exercise imaging. Treatments for aortic stenosis and mitral regurgitation have to be offered especially in urgent indications and in patients with advanced disease and poor prognosis. Expert risk stratification is essential for triage and setting the priority lists. In any case, appropriate level of personal protection must be ensured for healthcare personnel to prevent spreading infections and preserving specialized manpower to supply for the continuing need of handling chronic serious cardiovascular disease. Importantly, as soon as the local epidemic situation improves, efforts must be made to rebuild standard opportunities for elective treatment of valvular heart disease and occluder-based therapies according to existing guidelines, thus rebuilding stat-of-the-art cardiovascular services.","Kardiol Pol","Plonska-Gosciniak, Edyta","Suwalski, Piotr","Bartus, Stanislaw","Kukulski, Tomasz","Komar, Monika","Wojakowski, Wojciech","Grygier, Marek","Pruszczyk, Piotr","Gasior, Zbigniew","Huczek, Zenon","Berger-Kucza, Adrianna","Bak, Janusz","Sorysz, Danuta","Kasprzak, Jaroslaw D","32415767"],"abstract":["Ongoing pandemics of SARS-CoV-2 coronavirus disease 2019 (COVID-19) represents a major challenge for healthcare. Beside the proven involvement of cardiovascular system in COVID-19, increased healthcare system resources are redirected towards handling infected patients and thus induce major changes in access to services and priorities in the management of patients with unrelated chronic cardiovascular disease. This document, created by task force involving Working Groups on Valvular Heart Disease and Cardiac Surgery as well as Association of Cardiovascular Intervention, Polish Cardiac Society proposes modifications of diagnostic pathways, principles of healthcare professionals protection and guidelines for treatment according to triage and prioritization. Valvular heart teams should continue working with utilization of telemedicine and digital technology. Diagnostic tests must be simplified or deferred to minimize potentially dangerous aerosol generating procedures such as transesophageal echocardiography or exercise imaging. Treatments for aortic stenosis and mitral regurgitation have to be offered especially in urgent indications and in patients with advanced disease and poor prognosis. Expert risk stratification is essential for triage and setting the priority lists. In any case, appropriate level of personal protection must be ensured for healthcare personnel to prevent spreading infections and preserving specialized manpower to supply for the continuing need of handling chronic serious cardiovascular disease. Importantly, as soon as the local epidemic situation improves, efforts must be made to rebuild standard opportunities for elective treatment of valvular heart disease and occluder-based therapies according to existing guidelines, thus rebuilding stat-of-the-art cardiovascular services."],"journal":"Kardiol Pol","authors":["Plonska-Gosciniak, Edyta","Suwalski, Piotr","Bartus, Stanislaw","Kukulski, Tomasz","Komar, Monika","Wojakowski, Wojciech","Grygier, Marek","Pruszczyk, Piotr","Gasior, Zbigniew","Huczek, Zenon","Berger-Kucza, Adrianna","Bak, Janusz","Sorysz, Danuta","Kasprzak, Jaroslaw D"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32415767","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.33963/KP.15358","locations":["Polish"],"countries":["Poland"],"countries_codes":["POL|Poland"],"topics":["Prevention"],"weight":1,"_version_":1666994545911398400,"score":218.90913},{"pmid":32310920,"title":"[The role of multimodality imaging in COVID-19 patients: from diagnosis to clinical monitoring and prognosis].","text":["[The role of multimodality imaging in COVID-19 patients: from diagnosis to clinical monitoring and prognosis].","The integrated clinical, laboratory and ultrasound approach is essential for the diagnosis, monitoring and evaluation of the patient's therapy in COVID-19 pneumonia. The ideal imaging strategy in this setting is not yet well defined. Bedside pulmonary ultrasound presents an undeniable series of advantages in patients at high risk of infection, and can provide incremental data in the respiratory intensive care for the serial control of the individual patient, as well as for home delivery of stabilized patients. Chest X-ray is characterized by low sensitivity in identifying earlier lung changes. Pulmonary computed tomography shows high sensitivity but should not be routinely performed in all patients, because in the first 48 h it can be absolutely negative, and in the late phase imaging findings may not change the therapeutic approach. Echocardiography should be limited to patients with hemodynamic instability.","G Ital Cardiol (Rome)","D'Andrea, Antonello","Di Giannuario, Giovanna","Marrazzo, Gemma","Riegler, Lucia","Mele, Donato","Rizzo, Massimiliano","Campana, Marco","Gimelli, Alessia","Khoury, Georgette","Moreo, Antonella","32310920"],"abstract":["The integrated clinical, laboratory and ultrasound approach is essential for the diagnosis, monitoring and evaluation of the patient's therapy in COVID-19 pneumonia. The ideal imaging strategy in this setting is not yet well defined. Bedside pulmonary ultrasound presents an undeniable series of advantages in patients at high risk of infection, and can provide incremental data in the respiratory intensive care for the serial control of the individual patient, as well as for home delivery of stabilized patients. Chest X-ray is characterized by low sensitivity in identifying earlier lung changes. Pulmonary computed tomography shows high sensitivity but should not be routinely performed in all patients, because in the first 48 h it can be absolutely negative, and in the late phase imaging findings may not change the therapeutic approach. Echocardiography should be limited to patients with hemodynamic instability."],"journal":"G Ital Cardiol (Rome)","authors":["D'Andrea, Antonello","Di Giannuario, Giovanna","Marrazzo, Gemma","Riegler, Lucia","Mele, Donato","Rizzo, Massimiliano","Campana, Marco","Gimelli, Alessia","Khoury, Georgette","Moreo, Antonella"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32310920","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1714/3343.33132","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138491264696320,"score":216.36613}]}